NSTG
$39.36
Nanostring Tech
$2.03
5.44%
NSTG
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.57)
Revenue:  N/A
Monday
Nov 9
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NSTG reports earnings?
Beat
Meet
Miss

Where is NSTG's stock price going from here?
Up
Flat
Down
Stock chart of NSTG
Analysts
Summary of analysts' recommendations for NSTG
Score
Grade
Pivots
Resistance
$43.53
$41.59
$40.47

$38.53

Support
$37.42
$35.48
$34.36
Tweet
Growth
Description
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesSeattle GeneticsBluebird BioQiagen N.V.RepligenNovavaxBio-Techne